Enable Block: 

Scientists have warned that humans should brace for the emergence of a new virus that could be deadlier than Ebola Virus Disease (EVD), Severe Acute Respiratory Syndrome (SARS) or Zika.

Ebola virus disease (EVD) is a highly lethal condition for which no specific treatment has proven efficacy. In September 2014, while the Ebola outbreak was at its peak, the World Health Organization released a short list of drugs suitable for EVD research. Favipiravir, an antiviral developed for the treatment of severe influenza, was one of these. In late 2014, the conditions for starting a randomized Ebola trial were not fulfilled for two reasons.

Rapid sequencing of RNA/DNA from pathogen samples obtained during disease outbreaks provides critical scientific and public health information. However, challenges exist for exporting samples to laboratories or establishing conventional sequencers in remote outbreak regions. We successfully used a novel, pocket-sized nanopore sequencer at a field diagnostic laboratory in Liberia during the current Ebola virus outbreak.

The World Health Organisation declared an end to the deadliest Ebola outbreak ever on Thursday after no new cases emerged in Liberia, though health officials warn that it will be several more month

Since October 2014 the Ebola epidemic in West Africa has been diminishing and efforts have shifted from emergency response to prevention and mitigation of future outbreaks.

The second component of the Ebola Community Action Platform Project or ECAP-2 was launched in Tubmanville, Neekreen Administrative District of Grand Bassa County on Saturday, 12 December.

The first full-scale genomic analysis of the Ebola virus has been performed.

Government officials in West African countries affected by the Ebola Virus Disease (EVD) outbreak allegedly mismanaged and dubiously appropriated funds for relief from the epidemic, a recent report

The current outbreak of Ebola virus disease (EVD) centered in West Africa is the largest in history, with nearly ten times more individuals contracting the disease than all previous outbreaks combined. The details of human-to-human and zoonotic ebolavirus transmission have justifiably received the largest share of research attention, and much information exists on these topics.

The Ambassador of Japan based in Senegal, Takashi KITAHARA, will on the 27 November 2015 attend in Banjul a ceremony for two projects granted by the government of Japan to fight against the Ebola e